Results 151 to 160 of about 75,591 (303)
CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 435-447, March 2025.Abstract Intranasal diamorphine (IND), approved for managing breakthrough pain in the UK, has been identified as an acceptable alternative offering effective, expedient, and less traumatic analgesia for children. However, the current dose regimen in pediatric populations relies on clinical expertise while the pharmacokinetics properties are poorly ...
Lianjin Cai +6 more
wiley +1 more source
Evaluation of Potential Hormonal Activities of Ashwagandha (Withania somnifera)
Phytotherapy Research, EarlyView.ABSTRACT Ashwagandha is a widely used herb in traditional medicine systems, particularly Ayurveda. Despite its extensive tradition, growing concerns regarding its potential endocrinological effects have prompted scientific scrutiny. This review systematically evaluates the current preclinical, clinical, and case study evidence concerning AS's effects ...
Günter Vollmer, Thomas Brendler
wiley +1 more source
Nurse Practitioners and Opioid Use Disorder
Since the 1990s, the opioid epidemic has seen increase in the number of opioid-related deaths. Currently, the only approved treatment for opioid use disorder (OUD) is Medication Assisted Treatment (MAT). The need for providers to be more comfortable with
Louisa Tali, and Juanita Takeno
core
An Age‐Friendly Approach to Caring for Chronic Lung Disease in the Ambulatory Setting
Respirology, EarlyView.ABSTRACT Many common chronic lung diseases, such as chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD), have much greater prevalence among older adults and as a result, pose a substantial burden of morbidity, disability, and mortality. The care of older adults with chronic lung disease necessitates an age‐friendly approach
Angela O. Suen +3 more
wiley +1 more source
Small, EarlyView.This study presents a novel dual‐layer microneedle platform for psoriasis treatment, integrating rapid itch relief with sustained immunomodulatory and antibacterial effects. By combining difelikefalin and methotrexate‐zinc, this system effectively targets pruritus, epidermal hyperplasia, immune dysregulation, and infection, offering a promising ...
Xiaolong Xu +5 more
wiley +1 more source
Accessing Opioid Use Disorder Resources in Vermont
, 2019 A handout listing contact information for opioid use disorder resources in ...
Hou, Wendy
core
US State Policy Contexts and Mental Health Among Working‐Age Adults
The Milbank Quarterly, EarlyView.Policy Points States’ overarching policy contexts are a meaningful yet overlooked predictor of adults’ mental health, with more conservative contexts associated with worse mental health outcomes over a 30‐year period. Counterfactual analyses suggest that widespread policy shifts could meaningfully alter the national prevalence of mental distress ...
ILIYA GUTIN +4 more
wiley +1 more source
Early findings on home delivery of buprenorphine and retention in treatment for opioid use disorder.
Individuals with opioid use disorder face barriers accessing first-line pharmacotherapy. Home delivery interventions have been shown to improve medication adherence for other chronic diseases, but the relationship between buprenorphine home delivery and ...
Justin Coffey, M +6 more
core +1 more source
The Milbank Quarterly, EarlyView.Policy Points States contract with Medicaid managed care plans to administer benefits for roughly 70 million Medicaid enrollees, yet little is known about how plan benefit policies for substance use disorder (SUD) treatment medications align with state requirements.
SAGE R. FELTUS +6 more
wiley +1 more source
Research Ethics in Stopping Opioid Use Disorder Medication. [PDF]
JAMA PsychiatryWeiss RD, Nunes EV, Provost SE.
europepmc +1 more source